In this study, compared to healthy individuals, the complement system and the IL-6/JAK/STAT signaling pathway are activated in both the kidneys and peripheral blood cells of FSGS patients, and their activation levels are correlated with the severity of the disease (19, 20). Here, IL6 is linked to focal segmental glomerulosclerosis.